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 Abstract: In this mini-review, we highlight the potential of the biopolymer bacterial cellulose to treat 
damaged epithelial tissues. Epithelial tissues are cell sheets that delimitate both the external body sur-
faces and the internal cavities and organs. Epithelia serve as physical protection to underlying organs, 
regulate the diffusion of molecules and ions, secrete substances and filtrate body fluids, among other 
vital functions. Because of their continuous exposure to environmental stressors, damage to epithelial 
tissues is highly prevalent. Here, we first compare the properties of bacterial cellulose to the current 
gold standard, collagen, and then we examine the use of bacterial cellulose patches to heal specific ep-
ithelial tissues; the outer skin, the ocular surface, the oral mucosa and other epithelial surfaces. Special 
emphasis is made on the dermis since, to date, this is the most widespread medical use of bacterial cel-
lulose. It is important to note that some epithelial tissues represent only the outermost layer of more 
complex structures such as the skin or the cornea. In these situations, depending on the penetration of 
the lesion, bacterial cellulose might also be involved in the regeneration of, for instance, inner connec-
tive tissue. 
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1. INTRODUCTION 
 Epithelial tissues are, essentially, continuous cell sheets 
that delimitate both the external body surfaces and the inter-
nal cavities. Epithelia have a reduced content of extracellular 
matrix and exhibit strong cell-to-cell adhesions known as 
tight junctions. Epithelial tissues are not vascularized and 
receive support from the underlying basement membrane 
formed by connective tissue. Examples of epithelial tissues 
are the external linings of the skin, cornea and mouth but 
also those from the hollow internal organs such as lungs, 
digestive system, urogenital conducts and spinal cord. De-
pending on its location in the body, epithelia can be found as 
single (e.g., intestines, lungs) or multiple cell layers (e.g., 
skin, cornea, esophagus). The glandular epithelium that sur-
rounds the glands in our body is a highly specialized epithe-
lium that will not be addressed here. In this manuscript, we 
have used “epithelial tissue” as an umbrella term to refer to 
diverse body surfaces and barriers. 
 Epithelial structures physically protect the underlying 
tissues, regulate the diffusion of molecules and ions, secrete 
substances and filtrate body fluids among other vital func-
tions. Because of their surface location, epithelia are  
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constantly exposed to environmental stressors ranging from 
infections caused by microorganisms and mechanical inju-
ries to the exposure to toxic chemicals. Moreover, epithelial 
tissues are also greatly affected by inflammatory diseases 
and cancers. Despite the extraordinary regenerative capacity 
of epithelial tissues, they can be overwhelmed by large-area 
injuries, surgical scissions, burns or ulcers which might re-
sult in chronic lesions [1]. Additionally, diabetes, infectious 
processes, systemic and chronic treatments or other patho-
logical conditions can make epithelial regeneration less effi-
cient [2]. In these specific cases, the use of biomaterials to 
assist the regeneration of sensitive epithelia becomes vital.  
 Biomaterials represent a core element of regenerative 
therapies and are used in multiple ways to treat epithelial 
defects. Biomaterials are designed to interface with biologi-
cal systems to evaluate, treat, increase or replace tissues, 
organs or functions in the body (European Society for Bio-
materials, 2nd Consensus Conference on Definition, 1991). 
The palette of available biomaterials is extensive being poly- 
mers, ceramics and metals the main categories. Ceramics and 
metals are indicated for bioengineering load-bearing struc-
tures and are out of the focus of this minireview. Polymeric 
biomaterials are often classified into synthetic and natural 
polymers according to its origin. Because of its superior bio-
compatibility and bioactivity, naturally-occurring polymers 
(e.g., collagen, fibrin, chitosan, keratin, silk, alginate, cellu-
lose) are frequently used for repairing epithelial tissues. Bi-
omaterials based on natural polymers can serve as transitory 
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treatments like wound coverages [3], temporary skin substi-
tutes [4], carriers for cell therapy [5, 6] and drug delivery 
platforms [7, 8] as well as long-term replacements for dam-
aged epithelial tissues [9, 10].  
 Despite the broad spectrum of natural polymers and natu-
ral-natural [11] or natural-synthetic [12] composites that are 
being investigated for epithelial regeneration, currently, the 
main clinical procedures rely on collagen-based solutions 
[13]. Collagen is a fibrous structural protein that forms triple 
helix assemblies; it is a major constituent of the extracellular 
matrix and inherently bioactive and biocompatible. It is 
therefore understandable that collagen has long been consid-
ered the gold standard to repair organs and tissues (skin, cor-
nea, oral mucosa etc.) exposed to the environment. Collagen 
is primarily obtained from livestock sources like cow, pig, 
rat and more recently also from fish [14] and typically needs 
extensive manipulation prior to attaining the final product. 
One of the main drawbacks of animal collagen is its moder-
ate immunogenicity [15] and its high batch-to-batch variabil-
ity. On the other hand, religious constraints against animal 
derived medical products also have played a role [16]. Re-
combinant collagen from bacteria or plants [17] can help to 
overcome these issues but the production is still far from 
meeting the worldwide increasing collagen demand [18]. 
Last but not least, the mechanical properties and degradation 
kinetics of collagen do not always meet clinical require-
ments. Thus, novel biomaterials able to fulfill the enormous 
diversity of conditions and patients’ needs are required. 
 Third generation natural biomaterials are expected to be 
biocompatible as well as to foster the regeneration of dam-
aged tissues. To achieve this, researchers are screening not 
only alternative biopolymers [19] but also novel architec-
tures of already well-known natural materials [20]. In line 
with this, nanostructured biomaterials, typically in the form 
of nanofibrous hydrogels, have recently attracted much at-
tention [21-23]. Nanostructuration can endow biomaterials 
with high surface area to volume ratios, enhanced cell at-
tachment and proliferation; mechanical stability and ade-
quate porosity [24]. Such nanostructured substrates can be 
fabricated for instance by electrospinning [25]. Electrospin-
ning has already allowed forming gelatin and gelatin-
alginate nanofibers with improved mechanical properties 
compared to unstructured hydrogels [26]. Silk fibroin elec-
trospun nanomatrices showed reduced inflammation and 
faster re-epithelization in a rat burn model compared to con-
ventional treatments [27]. These authors partially ascribed 
the over-performance of the nanostructured wound dressing 
to the nanoscale dimensions of the fibers that accurately 
mimic the properties of soft tissues and retain certain 
amounts of liquid. 
 A lesser explored family of natural biopolymers with 
potential applicability in epithelial regeneration are 
nanocelluloses [28]. The term “nanocellulose” refers to cel-
lulose-based materials with at least one dimension in the 
nanoscale. Nanocelluloses can be subdivided into bacterial 
cellulose (BC), cellulose nanofibrils (CNF) and cellulose 
nanocrystals (CNC). CNF and CNC are commonly obtained 
from plant/wood cellulose after mechanical and/or chemical 
treatments while BC is biotechnologically produced by mi-
croorganisms using different carbon sources [29]. The three 
types of nanocellulose have been proposed for a diversity of 
medical and/or pharmaceutical applications. Regarding 
plant-derived nanocellulose hydrogels, recent encouraging 
applications include renewable and xeno-free wound dress-
ings for skin graft donor sites [30] as well as controlled drug 
release platforms for both low and high molecular weight 
substances [31]. As an alternative to CNC and CNF, cellu-
lose produced by microorganisms is emerging as a promising 
natural source of ready-to-use nanocellulose for medical and 
pharmaceutical applications.  
2. BACTERIAL CELLULOSE 
 BC is produced extracellularly by Gram-negative bacte-
rial cultures such as Gluconacetobacter, Acetobacter, Agro-
bacterium, Achromobacter, Aerobacter, Sarcina, Azobacter, 
Rhizobium, Pseudomonas, Salmonella and Alcaligenes. 
Among them, the most efficient BC producer belongs to the 
Komagataeibacter genus, specifically called Komaga-
taeibacter xylinus (K. xylinus) [32, 33]. The observation that 
Acetobacter xylinus produces a gelatinous mass on liquid/air 
interfaces has been known since 1886 by the work of A.J. 
Brown [34]. This gelatinous mass was later identified as BC. 
The bacterium uses the nanofibrous film to protect itself 
from environmental stresses such as dehydration, nutrient 
deficiency and UV radiation. In addition, the BC allows the 
bacteria to float and to remain at the interface between medi-
um and air thus increasing oxygen supply. 
 BC can conveniently be produced in laboratories follow-
ing the process summarized in (Fig. 1). The bio-synthesis 
starts with the inoculation of a culture medium with a BC-
producing bacteria strain (Fig. 1A). A typical culture medi-
um contains the following compounds: 2% (w/v) glucose, 
0.5% (w/v) yeast extract, 0.5% (w/v) peptone, 0.3% (w/v) 
sodium hydrogen phosphate and 0.1% (w/v) citric acid 
(Hestrin-Schramm (HS) culture medium) [35]. At molecular 
level, the biosynthesis of BC in the microorganism can be 
divided into four sub steps (Fig. 1B). First, phosphorylation 
of glucose by a glucokinase occurs (a) in the nucleus, fol-
lowed by isomerization of glucose-6-phosphate to glucose-1-
phosphate (b). Finally, it reacts with UDPG-pyrophosphory- 
lase to form uranyl diphosphate-glucose (UDPG) (c), fol-
lowed by the synthesis of BC by a cellulose synthase (d). 
The last step in the cytoplasm is a chain growth at the re-
duced end of the β-1,4-glucan chains by UDPG to form cel-
lulose fibers [36].  
 In the extracellular space, the unassembled cellulose 
chains aggregate into fibrils. These fibrils usually consist of 
10-15 fibers, have an approximate width of 15 nm and form 
microfibrils, which are arranged in cellulose bands with a 
width of approximately 80 nm [37]. This mechanism ex-
plains the three-dimensional cross-linked BC microstructure 
depicted in (Fig. 1D). The structure of the cellulose network 
can be affected by variation of bacteria strain, culture medi-
um, pH value, temperature and mechanical stresses. With 
static cultivation, BC in form of fleeces or thin films is ob-
tained, whereas agitated cultivation results in irregular ag-
gregated, fibrous structures or spheroidal particles (Fig. 1C) 
[38]. 
 The as-synthetized BC membranes exhibit unique prop-
erties proving its adequacy for epithelial regeneration pur-
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poses such a high degree of polymerization (4,000 -
 10,000) [28] and crystallization (up to 90%) [39]. For medi-
cal applications, the high mechanical stability, the lack of 
immunogenicity and the high purity are of particular rele-
vance [38, 40]. The biocompatibility of BC cannot solely be 
attributed to the high purity of the material but also to its 
similar organization of the fibers as in native collagen [41]. 
Despite the identical chemical structure of BC and plant-
based cellulose [42], BC clearly defines itself by its structure 
and material properties. The three-dimensional interwoven 
network of BC is characterized by a high surface area of 35 –
 40 m2/g (measured in freeze-dried form) [43, 44] and a wa-
ter content of about 99% [45]. The latter characteristic is the 
reason why BC is also called a “hydropolymer” or “hydro-
gel” [39]. Moreover, BC exhibits high temperature stability 
which allows temperature sterilization processes [46].  
 Last but not least, the attractiveness of this innovative 
biofabricated material has further increased due to its animal 
and human-free origin [47]. Its biosynthesis opens up the 
opportunity to develop biotechnological production to signif-
icantly influence and control the final BC shape and material 
features. Shapes, especially designed to come into contact 
with epithelial tissue, range from thin foils and fleeces used 
as covering, patch or dressing, tubes for artificial blood ves-
sels [48] to preformed structures for implantation (e.g., arti-
ficial meniscus [46] and ear cartilage replacement [49]). In 
recent years, enormous progress in BC cultivation techniques 
has been made to provide tailored-made and high-quality BC 
based materials. In parallel, the possibility to scale up BC 
production may broaden BC applicability in the near 
future [28].  
 To facilitate contextualization, a comparison between the 
hallmarks of BC and collagen, can be found in Table 1. 
3. APPLICATIONS OF BC IN EPITHELIAL REGEN-
ERATION 
 In this section, several applications of BC in epithelial 
regeneration are summarized. Special emphasis is made on 
dermal treatments since, to date, this is the most widespread 
medical use of BC. Afterward, less studied applications of 
BC in epithelial regeneration identified as the most promis-
ing current research directions are compiled. 
3.1. Dermal Applications 
 Skin is the largest and outermost human organ and covers 
the entire external body surface. Therefore, above all, the 
skin’s primary function is to protect the underlying muscles, 
bones, ligaments and internal organs from external biological 
and chemical agents as well as physical influences [70, 71]. 
Furthermore, skin is also involved in sensation, temperature 
regulation, immunological surveillance, prevention of dehy-
dration and synthesis of vitamin D3 [72]. The large epitheli-
um of the skin, which is responsible for the barrier function 
against infection and waterproofing, is called epidermis. This 
outermost layer of the skin is a stratified squamous epitheli-
um, composed of proliferating basal and differentiated su-
prabasal keratinocytes. The epidermis contains no blood ves-
sels, and cells in the deepest layers are nourished by diffu-
sion from blood capillaries extending to the upper layers of 
the dermis [73]. The integrity of this organ can be affected 
by cuts, burns, ulcers, surgical incisions or illnesses,
Fig. (1). Schematic representation of the basic BC generation process steps. (A) Formation process of BC fleece during cultivation of 
K. xylinus in HS medium in Erlenmeyer flasks. (B) Metabolic pathway of cellulose formation. (C) BC produced in different shapes. (D) 
Scanning electron microscopy (SEM) picture of BC porous middle layer depicting its three-dimensional fiber network. (E) Layered structure 
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Table 1. Comparison between collagen (as a benchmark material) and bacterial cellulose regarding relevant properties of bio-
materials for epithelial regeneration. 
Property Collagen Bacterial Cellulose 
Macrostructure 

















Triple helix protein fibers organized in 3D a network.  
























Building blocks Amino acids, mainly glycine, proline and hydroxyproline β-1,4-linked D-glucose units 
Origin 
Mainly, livestock animals (cow, pig). Also plants [53] 
and fish [14]
Bacterial cultures, mainly Komagataeibacter xylinus strains 
Purity Variable Very high  
Fiber cross-section ≈ 100 nm [54] 20-100 nm [28] 
Fiber length ≈ 1 µm [54] > 1 μm, hard to determine precisely 
Interwoven fibers Yes  Yes 
Degree of polymerization > 1400 4,000-10,000 [28] 
Molecular weight High High 
Options for structuration 
Fiber alignment [55, 56] 
Sacrificial templates [57] 
Fiber alignment [58] 
Templates during biosynthesis [59] 
Fiber Crystallinity Non consensus  
High (≈ up to 90% [60]), mix between Iα and Iβ cellulose 
structures 
Porosity 
Very variable depending on collagen source and fabrica-
tion method 
35-99% [50, 61, 62] 
Very variable depending on the drying method and posterior 
treatments  
60% -95 % [51, 61, 63]   
Pore type and size 
Interconnected pores with variable size: 26 [61] - 200 µm 
(SpongeCol®) 
Multi-size Native BC ≈5 µm.  
Can be modified with porogens (40 µm in [64]) and by in situ 
modifications [65]  
Water content 98% [50] 99% 
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Property Collagen Bacterial Cellulose 
Temperature stability 200 ºC [66] Up to 300 ºC 
Biodegradability High, ≈ 1 month in vitro [62] Low/none in the body, biodegradable by cellulases 
Biocompatibility High High 
Immunogenicity Low/moderate Low 
Bioactivity High, supports cell attachment and proliferation 
Tunable Moderate as-synthetized, increases after modifica-
tion [63, 67, 68] 
Mechanical stability  
Very variable: low in native collagen [13], increases 
after crosslinking [5] 
High in general. Reported to be higher than collagen [61], to 
be improved after surface modification [69] and to recapitu-
late native cartilage [49]  




High in the food form nata de coco (500-1500 tons per year 
per producer) and cosmetics but still low for  high quali-
ty/purity (medical-pharmaceutical grade)  
 
such as diabetes [74]. When the skin integrity is compro-
mised, its structure and functions must be re-established as 
soon as possible to recover tissue homeostasis. To accom-
plish that, the wound healing process should begin almost 
immediately after a skin injury occurs, in order to avoid bac-
terial infection and dehydration [75, 76]. Due to the proper-
ties described above, BC is a promising biomaterial for heal-
ing skin injuries. In fact, BC has already been used as a natu-
ral polymeric wound care material since the 80s [77, 78]. BC 
meets many of the requirements of an ideal wound dressing: 
it acts as a physical barrier against bacterial infections, al-
lows gas exchange, absorbs exudates, keeps a moist envi-
ronment that enhances reepithelization, and is easy to re-
move without pain. [79, 80] Furthermore, BC is non-toxic 
and non-allergenic as described [36].  
 Today, several types of BC based wound dressings pro-
vided by different companies are on the market. The first 
BC-based medical product on the market was Biofill®, a thin 
BC film with a water content of 8.5% used as temporary skin 
substitute and biological wound dressing. It has been suc-
cessfully applied for the treatment of several skin injuries 
such as basal cell carcinoma, severe burns, dermabrasions, 
chronic ulcers as well as at donor and receptor sites in skin 
grafts. Among other benefits, immediate pain relief, close 
adhesion to the wound bed, spontaneous detachment follow-
ing reepithelization and reduced treatment times as well as 
costs have been reported for this product. The only flaw dis-
cussed in some reports was the limited elasticity, when ap-
plied in areas of great mobility [77]. Along with the rising 
trend for modern moist wound management, clinical investi-
gations of wet, never-dried BC for both, chronic wounds and 
burns, followed [81, 82]. Moist BC-based dressings such as 
XCell® were described as more effective than conventional 
wound dressing materials in promoting autolytic debride-
ment, accelerating granulation and simultaneously donating 
and absorbing moisture from the wound [82].  
 Some recent studies on dermal BC applications focused 
on the understanding of the accelerated healing observed for 
both, dry and wet BC wound dressings, and thus contributed 
to a better understanding of the effects. Kwak and col-
leagues [83] performed an in vivo study on rats and reported 
on distinct improvements in thickness of both, epidermis and 
dermis, as well as the number of blood vessels and an inhibi-
tion of the infiltration of mast cells at indicated time points in 
case of BC treated burns compared to gauze. The authors 
hypothesized that BC may accelerate the process of wound 
healing in burn injuries through regulation of angiogenesis 
and connective tissue formation. 
 Li and colleagues [84] evaluated the eect of the struc-
ture of BC on full-thickness skin wound repair. The hierar-
chical structure of BC films and their dierent eects on skin 
wound healing were studied both in vitro (in a wound heal-
ing model placed on a microfluidic chip) and in vivo (Wistar 
rats). The results indicated clear benefits of BC in the 
healing of full-thickness wounds compared to gauze in terms 
of inflammatory reaction and healing time. The in vivo and 
ex vivo experiments on rats also demonstrated a certain dif-
ference in performance of both sides of the BC pellicle. The 
bottom side of the BC film promoted blood vessel regenera-
tion and collagen production of the wounds more than the 
top side. The authors argued that a looser BC network also 
promotes cell migration and proliferation and suggested het-
erogeneous BC-based biomaterials for complex tissue engi-
neering. However, they did not investigate yet, whether a 
higher porosity and surface roughness may compromise the 
easy and pain-free detachment after reepithelization reported 
for BC wound dressings. 
 Cavalcanti et al. recently published the outcome of a ran-
domized and controlled trial investigating the efficacy of 
perforated dry BC membranes for the treatment of lower 
limbs chronic varicose ulcers [79]. In the BC group, ulcers 
were more superficial at the end of the observation period 
(120 days) in more than 80% of the patients (versus 60% in 
the control group treated with triglyceride oil and gauze). 
The authors suggested that BC dressings could act as an in-
ducer of tissue remodeling, stimulating the granulation pro-
cess. They stressed the fact that the ulcer healing depends 
not only on the epidermal proliferation at the margins of the 
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lesion but also on the growth of the granulation tissue from 
the central area. 
 Several modifications allow to further increase the func-
tionality of BC as wound care device while keeping the es-
sential BC properties of biocompatibility and nanofibrillar 
structuration. Modifications of the cellulose can be obtained 
during the biofabrication process (in situ) e.g. using additives 
and by post-modification such as drying, chemical function-
alization or loading of the BC network with active ingredi-
ents. An excellent overview of BC in various modifications 
developed for wound healing applications can be found by 
Sulaeva et al. [33]. However, some recent findings are high-
lighted in (Table 2) and discussed below. 
3.1.1. Material Modifications 
 Modifications of the BC such as control the water con-
tent, surface topography and nanocomposites have been ap-
plied to improve wound healing. Rebelo et al. recently inves-
tigated the effects of varying water content on BC material 
properties. They demonstrated that the dehydration effects 
on BCs viscoelastic and electrochemical properties. Lower 
water contents as 80% and 50% caused increased stiffness 
and BC resistance to electron transfer became higher with 
lower electron capacity [96]. Those findings have implica-
tions for BC wound dressings with different moisture con-
tent. They may range from practical aspects such as handling 
and draping of the dressing to electrolyte exchange through 
the dressing. However, this should be investigated in further 
studies. Another group focused on modifications of the sur-
face topography of BC dressings in order to improve wound 
healing. Bottan and colleagues introduced a new approach 
called guided assembly-based biolithography (GAB) tech-
nology [85]. They developed PDMS molds with different 
surface patterns allowing a controlled in situ modification of 
the BC surface topography. The structured surface was 
shown to influence migratory patterns and alignment of hu-
man dermal fibroblasts and keratinocytes. A full-thickness 
wound model tested on mice confirmed the promotion of 
fibroblast infiltration and new collagen deposition in the 
wound bed by the modified dressing compared to flat BC. 
3.1.2. Combination of BC with Other Biomaterials 
 In many studies, BC has been combined with other bio-
materials known for their beneficial effects on wound heal-
ing. To give an example, Moraes and colleagues [97] inves-
tigated a self-prepared wound gel made from disintegrated 
bacterial cellulose and collagen type I (BC/COL). In an ani-
mal study, healing of surgical skin wounds in rat dorsum 
with BC/COL gel was compared with those from animals 
treated with commercial collagenase ointment and an un-
treated group. BC/COL hydrogel was found to be more effi-
cient than the collagenase ointment. Wound closure and fully 
repaired epithelium and dermis with organized collagen fi-
bers and tissue rich in blood vessels were observed at day 15. 
At the same time, the dermis was thinner in case of the col-
lagenase ointment treatment and still under repair with the 
presence of numerous inflammatory cells for the untreated 
group. Especially, the adhesion of the hydrogel on the 
wound bed was found to be advantageous for the treatment. 
 Other groups reported the combination of BC with silk-
sericin [98], chitosan [99] and dextrane [100]. Silk-sericin 
was selected due to its cytoprotective and mitogenic effects, 
whereas chitosan and dextrane were selected based on their 
antibacterial efficiency and positive effects on fibroblast cell 
proliferation, respectively. In all cases, positive effects of the 
combination compared to native BC were reported. 
 H. Wu et al. used bacterial cellulose nanocrystals (BCNCs) 
to reinforce regenerated chitin (RC) fibers to form 
BCNC/RC filaments for surgical sutures. Mechanical meas-
urements demonstrated that the strength of the BCNC/RC 
filament increased dramatically over the RC analogue. A 
yarn made of 30 BCNC-loaded fibers also achieved satisfac-
tory mechanical performance, with a knot-pull tensile 
strength of 9.8 ± 0.6 N compared to 6.8 ± 0.6 N of RC yarn 
without BCNC. While obtaining biocompatibility of the sur-
gical suture, enzymatic degradation rate can be tuned by var-
ying the concentration of BCNCs in the yarn. It has been 
proven that BCNC/RC promotes cell proliferation (in vivo) 
murine skin wound closure experiments, without any adverse 
effects. The combination of strength-enhanced fiber and 
promising in vivo experiments qualify BCNC/RC to be a 
new candidate for application as BC-based medical suture 
[86]. 
3.1.3. Drug-delivery Systems 
 Furthermore, an increasing number of studies report on 
drug delivery systems based on BC for dermal 
applications [47]. To avoid the risk of bacterial infections, 
e.g. Amoxicillin loaded BC sponges were examined [101]. 
The functionalized sponges displayed good porosity and 
swelling, which are beneficial for absorbing wound exu-
dates. Moreover, a wound infection model proved enhanced 
wound healing ability in vivo. In another study, antimicrobial 
peptides such as ε-poly-L-Lysine (ε-PLL) were investigated 
[94]. This peptide is a non-toxic biopolymer with broad-
spectrum antimicrobial activity. Fürsatz et al. cross-linked 
low molecular weight ε-PLL in pristine BC membranes and 
to carboxymethyl cellulose functionalized BC using car-
bodiimide chemistry. The functionalization of BC with ε-
PLL inhibited growth of S. epidermidis on the membranes 
but did not affect the cytocompatibility to cultured human 
fibroblasts as compared to native BC. The functionalization 
had no significant effects neither on the nanofibrous struc-
ture nor on the mechanical properties of the BC. Further-
more, there are recently published studies taking advantage 
of some classical approaches in cellulose chemistry applied 
to BC. e.g. Wu et al. used the 2,2,6,6-Tetramethyl-1-
piperidinyloxy (TEMPO) oxidation to obtain superficially 
oxidized bacterial cellulose pellicles (TOBCP) and subse-
quently loaded them with silver nanoparticles (TOBCP/ 
AgNP) [87]. Through this modification, they established 
antimicrobial activity by a silver ion release with a rate of 
12.2% per day at 37 °C in three days while retaining the bio-
compatibility of TOBCP.  
 Following the same purpose, other groups reported about 
the incorporation of zinc oxide nanoparticles into BC. The 
nanocomposites exhibited high antibacterial activity against 
Escherichia coli, Pseudomonas aeruginosa, Staphylococ-
cus aureus and Citrobacter freundii. In a burn wound model, 
animals treated with the BC/ZnO nanocomposite further 
showed a significant healing of 66% after 15 days related to 
day 0 compared to BC, which showed a healing of 50.5%
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Table 2. Modifications of BC and properties resulting from the modifications. 
Material Title of Paper Results Obtained by BC Modification 
BC with structured topography [85] Surface-structured bacterial cellulose with Guided 
Assembly-Based Biolithography (GAB) 
Improved cell alignment 
Promotion of fibroblast infiltration and new collagen deposi-
tion in the wound bed 
BCNC/RC [86] Regenerated chitin fibers reinforced with bacterial 
cellulose nanocrystals as suture biomaterials 
Biocompatible surgical sutures 
increasing strength of BCNC/RC filaments 
Enzymatic degradation possible 
Degradation rate can be tuned by varying concentration of 
BCNCs in the yarn 
Chitin can promote cell proliferation (in vivo) 
TOBCP/AgNP [87] TEMPO-Oxidized Bacterial Cellulose Pellicle 
with Silver Nanoparticles for Wound Dressing 
Antimicrobial activity  
Ag+ release with a rate of 12,2%/day at 37°C in 3 days 
Biocompatible wound dressing 
BC/ZnO [88] Bacterial cellulose-zinc oxide nanocomposites as a 
novel dressing system for burn wounds 
Antimicrobial activity against Escherichia coli, Pseudomonas 
aeruginosa, Staphylococcus aureus and Citrobacter freundii 
Significant healing of 66% after 15 days related to day 0 
BC/TiO2 [89] Bacterial cellulose-TiO2 nanocomposites promote 
healing and tissue regeneration in burn mice model 
Antimicrobial activity against Escherichia coli (81.0 ± 0.4%) 
and Staphylococcus aureus (83.0 ± 0%) 
BC/SMN-Zein [90] Drug release and antioxidant/antibacterial activi-
ties of silymarin-zein nanoparticle/Bacterial cellu-
lose nanofiber composite films 
Flavonoid silymarin (SMN) and zein loading through nano-
particle adsorbing onto BC nanofibers 
Change of wettability and swelling 
Antioxidant and antibacterial activity 
air-dried SMN-Zein/BC nanocomposite slow down the lipid 
oxidation 
BC/Octenidin [91] Controlled extended octenidine release from a 
bacterial nanocellulose/Poloxamer hybrid system 
Long term controlled release of octenidine up to one-week 
improved mechanical and antimicrobial properties. 
Ready-to-use system with Poloxamer loaded BC for ad-
vanced treatment of infected wounds 
Toxicity test performed with shell-less hen’s egg model 
BC/CMC/MTX [92] 
 
Effect of in situ modification of bacterial cellulose 
with carboxy-methylcellulose on its 
nano/microstructure and methotrexate release 
properties 
Impact of DS-CMC on methotrexate loading 
Topical treatment of psoriasis 
Decrease of the elastic modulus as the DS of CMC increased 
BC/PHEMA [93] Embedding of Bacterial Cellulose Nanofibers 
within PHEMA Hydrogel Matrices: Tunable Stiff-
ness Composites with Potential for Biomedical 
Applications 
New modification: in situ UV radical polymerization of HE-
MA monomer impregnated into wet BC nanofibrous structure 
Significant improvement in mechanical properties 
Tensile strength increased 
Non toxic 
rMSCs (rat mesenchymal stem cells) proliferation 
tissue replacement and wound healing 
BC/ ε-poly-L-Lysine [94] Functionalization of bacterial cellulose wound 
dressings with the antimicrobial peptide ε -poly-L-
Lysine 
Antimicrobial activity (broad-spectrum) without affecting the 
beneficial structural and mechanical properties 
Modification with non-toxic biopolymer 
ε-PLL inhibited growth of S. epidermidis on the membranes 
but did not affect the cytocompatibility to cultured human 
fibroblast 
(Table 2) contd…. 
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Material Title of Paper Results Obtained by BC Modification 
BC/PVA [95] Preparation and in vitro characterization of 
BC/PVA hydrogel composite for its potential use 
as artificial cornea biomaterial 
Higher visible light transmittance than plain BC  
BC/HA [60] Bacterial cellulose/hyaluronic acid composite 
hydrogels with improved viscoelastic properties 
and good thermodynamic stability 
Higher visible light transmittance than plain BC 
ABC/urinary bladder matrix [67] Acetylated bacterial cellulose coated with urinary 
bladder matrix as a substrate for retinal pigment 
epithelium 
Higher adhesion and proliferation of retinal pigment epitheli-
um cells than uncoated BC 
Closer recapitulation of the in vivo cell phenotype than un-
coated BC  
BC/varying porosity [64] Bacterial cellulose-based biomimetic nanofibrous 
scaffold with muscle cells for hollow organ tissue 
engineering 
Higher pore size than native BC to allow muscle cell in-
growth  
Higher porosity 
Small decrease in mechanical strength  
 
after the same treatment [88]. The incorporation of titanium 
dioxide nanoparticles (TiO2) in BC has also given encourag-
ing results [89]. Khalid et al. depicted in vivo burn wound 
healing potential of BC and TiO2 nanocomposites 
(BC/TiO2). Antimicrobial activity of the nanocomposite was 
against Escherichia coli (81.0 ± 0.4%) and Staphylococ-
cus aureus (83.0 ± 0.0%) was confirmed through agar disc 
diffusion protocol.  
 The combination of BC with natural substances or natu-
ral derived Active Pharmaceutical Ingredients (APIs) is be-
coming more and more notable. Tsai et al. investigated a 
composite film with silymarin-zein nanoparticles and BC 
nanofibers. They applied adsorption of flavonoid silymarin 
(SMN) and zein nanoparticles to load them onto the fibers 
for improving higher antioxidant and antibacterial activity. 
The authors could also show that air-dried SMN-Zein/BC 
nanocomposites slowed down lipid oxidation [90]. 
 Lima Fontes et al. have shown the effect of CMC in situ-
modifications on BC nano/microstructure and methotrexate 
(MTX) release properties. The degree of substitution of 
CMC (DS-CMC) has a massive impact on API loading; 
since carboxymethylcellulose (CMC) is a well-known candi-
date to change e.g. pore-sizes of the three-dimensional net-
work of BC. For topical skin application, MTX is used as 
disease-modifying anti-rheumatic drug for e.g. treatment of 
psoriasis. However, besides the impact of loading capacity, 
increasing DS-CMC causes a decrease of the elastic modulus 
of BC [92]. 
 Remarkable is also the new in situ-modification by UV 
radical polymerization of HEMA monomer impregnated into 
wet BC nanofibers. The combination of BC with poly(2-
hydroxyethyl methacrylate) depicted a significant improve-
ment in the mechanical properties (e.g. tensile strength) and 
the rat mesenchymal stem cells proliferation which qualifies 
this modification for tissue replacement and wound healing 
applications [93]. 
 Considering all these wound dressings loaded with an 
API as drug-delivery systems, most of the studies show ini-
tial bursts of the API release. Up to now, long-term con-
trolled release systems are still very rare. Nevertheless, 
Alkhatib et al. designed a new delivery system consisting of 
BC and Poloxamer developed for the antiseptic API octenid-
ine as a long-term ready-to-use system for dermal wound 
treatment (Fig. 2). This delivery system provides a prolonged 
retention time for octenidine, up to one week, with improved 
mechanical and antimicrobial properties as well as a high 
biocompatibility [91]. 
3.1.4. BC as Cell Carrier 
 Because of the possibility to support mammalian cell 
attachment and proliferation, BC films are also investigated 
as cell carriers in cell transplantation [102]. For instance, 
bacterial cellulose/acrylic acid (BC/AA) wound dressing 
hydrogels (without cells) enhanced wound healing capacity 
in nude mice. Interestingly, when the BC/AA hydrogels were 
loaded with human epidermal keratinocytes and human der-
mal fibroblasts, the positive effects of the BC/AA in burn 
recovery were accentuated. The in vivo results showed that 
the cell-loaded hydrogel produces the greatest acceleration 
on burn wound healing, followed by treatment with the hy-
drogel alone in comparison to the untreated group. The per-
centage wound reduction on day 13 in the mice treated with 
BC/AA hydrogel loaded with cells (77.3 ± 6.2%) was signif-
icantly higher than that in the control-treated mice (64.8 ± 
6.8%) or the hydrogel-treated ones alone (71.5 ± 2.3), re-
spectively. Histological analysis for the expression of colla-
gen type I via immunohistochemistry and transmission elec-
tron microscopy indicated a greater deposition of collagen in 
the mice treated with the hydrogel loaded with cells than in 
the mice administered with other treatments. Therefore, the 
BC/AA hydrogel proved promising applicability as a wound 
dressing and as a cell carrier. 
 In summary, very promising experimental investigations 
and preclinical studies have been performed suggesting the 
future application of modified, drug-loaded and/or native BC 
in an increasing number of dermal applications. The increas-
ing number of BC-based wound dressings on the market 
follow the same trend and confirm the high commercializa-
tion potential of innovative BC based medical products. Oth-
er fields of BC application in damaged epithelial tissues re-
generation are still in its infancies, as described below, but 
show the same promise. 
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Fig. (2). (a) Schematic overview of the loading of BC with Polox-
amers forming critical micelle concentration (CMC) and critical 
gelation concentration (CGC) samples. (b) Photographs of octenid-
ine and octenidine/Poloxamer loaded CMC and CGC BC samples 
and percentage uptake of octenidine (mean ± SD, n = 3) after incu-
bation of fleeces for 48 h by Alkathib et al. reproduced with per-
mission from Elsevier [91]. (The color version of the figure is avail-
able in the electronic copy of the article). 
3.2. Ophthalmology 
 Ophthalmology is a branch of medicine historically 
linked with the use of biomaterials, exemplified by contact 
and intraocular lenses. The application of biologically de-
rived materials in regenerative ophthalmology predominant-
ly concentrates on the ocular surface and, to a lesser extent, 
on the retina. [103] (Fig. 3) localizes these two tissues in a 
3D human eye anatomy representation. To date, for ocular 
surface wound healing, amniotic membrane patches are 
regularly applied [104] and the most common clinical ap-
proach for ocular surface reconstruction relies on corneal 
transplantation, whereas innovative regenerative medicine 
approaches are gradually gaining acceptance [105]. 
 The outermost part of eye comprises two epithelia: The 
corneal and the conjunctival epithelium. Recently, collagen 
based materials have been designed to reconstruct these two 
structures [106-109], while other authors developed silk or 
keratin-based membranes [110]. Some previous reviews al-
ready pointed out that the innate hydrophilicity, flexibility 
and mechanical stability of BC suggest a potential applica-
tion on corneal regeneration [111, 112]. One more strength 
of BC for this specific application is its conformability, 
which might facilitate the adaptation of the biomaterial to the 
dome shape of the ocular surface. BC has been shaped into a 
contact lens-like form by culturing K. xylinus on top of hy-
drophilic surfaces [113] and, in parallel, BC has proven to 
support the growth of human corneal stromal cells [114]. 
However, research papers on this topic are scarce and de-
scribe preliminary findings, indicating that the application of 
BC in ocular surface regeneration is still a field in its infancy 
that deserves to be explored in more depth. 
 Native-state BC has a visible light transmittance around 
70% due to the dispersive character of the fibers bundles and 
pores. In order to increase the transparency of BC for long-
term applications in corneal regeneration, BC has been com-
bined with other components such polyvinyl alcohol (PVA) 
[95]. BC/PVA composites, prepared by a freeze-thaw meth-
od, were satisfactorily evaluated in terms of water holding 
capacity, light transmittance, mechanical properties and 
thermal stability; important characteristics for a corneal sub-
stitute. However, no biological characterization of those ma-
terials have been published at the time of this review. Simi-
larly, BC/Hyaluronic acid composites (BC/HA) were pre-
pared by a physical gelation method with the resulting mate-
rial displaying 90% of visible light transmittance [60]. Inter-
estingly, this feature was maintained after a drying-rewetting 
cycle. According to the authors, biocompatibility tests for the 
BC/HA composites are in progress. 
 To our knowledge, the only in vivo assessment of BC as 
a corneal replacement was carried out by R. V. Sepúlveda  
et al. [115]. In this study, dry BC and BC/polycaprolactone 
(PCL) hydrogels were implanted into rabbit’s eyes to replace 
the corneas. Both BC and BC/PCL implants remained stable 
over the 45 days of the study and delayed the manifestation 
of corneal edema with respect to the control group that re-
ceived no treatment. Nevertheless, the authors report chronic 
inflammation and incomplete re-epithelization in the long 
term for the rabbits receiving the BC and BC/PCL implants. 
These results hint that the use of BC as a permanent corneal 
substitution will be challenging.  
 Another research direction regarding ophthalmological 
applications of BC is the repair of retinal pigment epithelium 
(RPE). The function of this highly specialized epithelium is 
impaired in patients suffering from age related macular de-
generation, the most common cause of vision loss in Europe 
[116]. Gonçalves et al. described that acetylated BC support-
ed the attachment and proliferation of RPE cells and envi-
sioned a potential application of BC as a carrier for RPE cell 
transplantation to the retina [117]. More recently, the same 
group reported a further functionalization of acetylated-BC 
(ABC) with urinary bladder matrix [67]. It is encouraging to 
read that when RPE cells were seeded on these substrates, 
they recapitulated closer the in vivo phenotype than on un-
coated ABC. 
 Taken together, these studies set the basis for future re-
search on BC-based biomaterials specifically targeting eye 
epithelia. The above-summarized results are still immature 
and, due to the lack of in vivo experiments, conclusions must 
be drawn with caution. Nevertheless, the field of regenera-
tive ophthalmology appears as an opportunity for the BC-
based biomaterials to find a potential niche in the health 
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3.3. Stomatology 
 Deliberations for potential applications of BC, e.g. tem-
poral implants in dental extraction alveoli or wound dressing 
after mucosal transplantation recently came up, but the test-
ing of BC and specific product developments are still rare. 
However, the softness of the hydropolymer plus its flexibil-
ity and self-attachment to surfaces strongly suggest a broader 
scope of application in dentistry. Studies of Weyell et al. 
depicted the benefits of doxycycline-loaded hydrated and 
freeze-dried BC in dental therapies such as dental extraction 
or mucosal transplantation [118]. Both applications would 
benefit on the one hand from a material, which degrades 
under physiological conditions and on the other hand from 
an antibiotic environment. Consequently, periodate-
oxidation of BC was performed to modify its degradation 
kinetics. In addition, native and oxidized BC loaded with 
doxycycline were tested for prophylaxis against infection. 
An in vitro toxicity test ensured biocompatibility of oxidized 
BC, whereas agar diffusion tests of samples loaded with 
doxycycline against pathogenic oral bacteria proved high 
antibiotic efficiency. Release studies of the drug from native 
and oxidized BC confirmed a comparable release behavior 
showing an initial burst of 50-60% within the first hour and a 
total release of about 90% after 3-5 h [119]. 
 Chiaoprakobbkij et al. developed freeze-dried composite 
sponges made from BC fibers and alginate, crosslinked with 
CaCl2. This recent in vitro study also showed a supported 
proliferation of human keratinocytes and gingival fibroblasts 
caused by this composite material [120]. In conclusion, there 
is still an unmet potential for BC-based products (e.g. perio-
dontal dressings, sponges, tamponades, sutures or even drug 
delivery systems) in dentistry. 
3.4. Other Epithelial Surfaces 
 Epithelial tissues form part of a myriad of membranes 
and barriers inside the human body. Some of these structures 
such as the eardrum, the meninges or the linings of hollow 
organs are difficult to rebuild after disease or trauma and 
would largely benefit from new repair approaches based on 
natural biomaterials. In this last section, we have grouped 
further applications of BC regarding the regeneration of di-
verse body surfaces. 
 The tympanic membrane (TM) separates the external ear 
form the middle ear and its key function is to amplify air-
borne vibrations and transduce them to the middle ear. TM 
perforation is a common clinical situation and implies a risk 
of prolonged damage and hearing reduction, especially if 
bacterial infection occurs. BC patches have been evaluated 
as wound healing devices in eardrum perforations to substi-
tute the muscle, fat or cartilage autografts that are conven-
tionally used in TM reconstruction. F. Coelho Alves Silveira 
et al. performed a randomized controlled trial with 40 pa-
tients and reported a higher success rate (90 vs 80%) when 
BC films were used as wound dressings respect to autolo-
gous temporal fascia (muscle) patches. Notably, the BC 
treatment reduced the operation time in more than one hour 
and the total hospitalization costs were 13 times lower. An-
other study tested the efficiency of BC to solve small but 
long-lasting TM perforations in 16 ears [121]. The authors 
conclude that the high rate of recovery of these patients 
treated with BC (81.3% of the cases) encourages for further 
investigations of BC in otology. Interestingly, this publica-
tion highlights, from a clinical point of view, some ad-
vantages of BC respect to other grafting materials for TM 
reconstruction: no need of general anesthesia for the surgical 
procedure, easy shaping of the material to match the defect 
size, enhancement of cell growth in the damaged area, easy 
sterilization and short operating time. 
 Because its limited endogenous regenerative potential, 
the nervous system is another area where BC patches could 
be of great interest. In particular, dura mater, the outermost 
of the three meninges that surround the brain and the spinal 
cord, is frequently disrupted after neurosurgical interventions 
or trauma and thus can be regarded as a potential target for 
BC-based treatments. In vitro, patterned BC substrates 
proved to support and guide the growth of neural stem cells 
[59]. In line with this, Goldschmidt and coworkers reported 
the proliferation of human dural fibroblasts (primary cul-
 
Fig. (3). Schematic representation of the human eye anatomy and the targeted tissues treated with BC-based therapies. Image modified from 
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tures) on BC films [122]. These authors propose BC as a 
conceivable option for dural implants principally because of 
its mechanical stability and its capability to support the 
growth and migration of native dural cells. In vivo, damage 
to dura mater has been experimentally treated with BC 
patches [123]. In this study, sutureless BC implants were 
inserted in 40 rats and examined after 120 days without no-
ticing any complication such as infection, cerebrospinal fluid 
leakage, hemorrhages or behavior disturbance in the animals 
during the study time. The levels of inflammation were simi-
lar between the group that received BC patches and the 
group implanted with a polytetrafluoroethylene-based mate-
rial (positive control). The authors claim a satisfactory level 
of BC graft acceptance and highlight the potential applica-
tion of BC in dura mater repair. Actually, in 2014 the com-
mercial product SYNTHECEL Dura Repair was launched 
for this specific application after showing an equivalent ef-
fectiveness compared to other commercially available prod-
ucts for dura replacement [124]. 
 BC native structure in the form of a fibrous hydrogel and 
some reported BC film thickness [51] are comparable to 
those of the mucus layers covering the body’s internal cavi-
ties [125, 126]. Thus, BC has also been proposed for recon-
struction of hollow organs [112] that is, urinary, reproduc-
tive, respiratory and intestinal tracks, which contain a muco-
sa on its inner side. To this end, asymmetric BC structures 
exhibiting one site with densely packed BC fibers and anoth-
er side with loose BC fibers were generated mimicking the 
architecture of tubular organs [64]. These scaffolds achieved 
higher porosity than native BC and after being seeded with 
muscle cells, were implanted in dog urinary systems yielding 
better outcomes than unmodified BC.  
 The findings summarized in this section collectively un-
derline the versatility BC and its potential to take part in the 
regeneration of diverse body surfaces. Likewise, the adapta-
bility of BC in terms of size, shape and porosity will be cru-
cial in the future to conceive tissue-specific biomaterials 
based on BC.  
CONCLUSION 
 The outstanding properties of BC, in conjunction with its 
natural origin and sustainable manufacturing call for many 
diverse applications in epithelial regeneration. Here, we pro-
vide a compact but detailed synopsis about the opportunities 
for BC-based alternatives to conventional treatments in this 
field.  
 Huge progress has been made in the development of nov-
el BC-based materials for dermal applications and in the 
understanding of their positive effects on wound healing. 
Approaches ranging from modifications of topography, wa-
ter content and pore structure to combinations with other 
biopolymers, active ingredients and/or cells have shown that 
BC is not only an excellent wound dressing material in its 
native form but also a versatile platform material to tailor-
made product design. Along with the increasing comprehen-
sion of the reasons for accelerated wound healing observed 
for native as well as modified BC, new BC-based medical 
products, designed for the treatment of specific skin lesions, 
can be expected to enter the market within the next couple of 
years.  
 Besides the well-known example of the outer skin, we 
pinpointed other epithelial surfaces that could benefit from 
innovative treatments based on BC. In the field of ophthal-
mology, the preliminary findings reviewed here should en-
courage future research on BC-based biomaterials specifical-
ly targeting eye epithelia since the field of regenerative oph-
thalmology appears as an opportunity for BC to find a niche 
in the competitive health market. Similarly, the softness of 
the BC hydrogels together with its flexibility and self-
attachment to body surfaces strongly suggest a broader scope 
of potential application in dentistry, a field that definitely 
deserves more research efforts. Worth noting are the reports 
on tympanic membrane reconstruction highlighting im-
portant advantages of BC compared to other grafting materi-
als from a clinical perspective: no need of general anesthesia 
for the surgical procedure, easy shaping of the material to 
match the defect size, enhancement of cell growth in the 
damaged area, easy sterilization and short operating time.  
 The potential of BC as cell carrier should not be underes-
timated. In this manuscript we gathered abundant examples 
of cell types that can effectively attach and proliferate on BC 
substrates. These cell types include diverse human cells; 
epidermal keratinocytes, dermal fibroblasts, corneal stromal 
cells, retinal pigment epithelium and other mammalian cells 
like neural stem cells (mouse) and muscle cells (dog). On top 
of that, BC exhibits potentiality as a substrate for stem cell 
transplantation as it proved to maintain stemness of mouse 
mesenchymal stem cells for a longer period of time than tra-
ditional culture methods [127].  
 Naturally, there are some difficulties that BC-based bio-
materials will need to overcome to effectively contribute to 
epithelial regeneration. When permanent replacement for 
epithelial tissue is targeted, BC should allow cell ingrowth to 
provide a proper integration of the biomaterial into the sur-
rounding tissue. So far, this can only be achieved when BC 
is specifically modified to increase porosity. Moreover, BC 
based (implant) materials need to degrade after fulfilling the 
intended medical purpose. Degradability of BC under physi-
ological conditions can only be achieved after chemical 
modification or enzymatic treatment and the verification of 
total degradation and metabolization in in vivo studies is still 
open. Likewise, for the specific application of long-term 
corneal replacement, BC will also need to be adapted to im-
prove visible light transmittance. 
 However, these limitations in some specific fields of 
medical application are already addressed in current research 
and will probably be overcome in the next years. The signifi- 
cant progress in controlled production and the successful 
design of bioreactors suited for industrial scale production of 
medical grade BC [38] already paved the way for faster 
commercialization. Together with the profound knowledge 
gained by young companies world-wide about the produc-
tion of BC based products according to current quality man-
agement and medical device regulations, this progress will 
significantly accelerate the market entrance of further BC 
based products including an increasing number of implant 
materials designed for epithelial regeneration. 
LIST OF ABBREVIATIONS 
API = Active Pharmaceutical Ingredient  
BC = Bacterial Cellulose  
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BC/AA = Bacterial Cellulose/Acrylic acid 
BC/COL = Bacterial Cellulose/Collagen 
BC/HA = Bacterial Cellulose/Hyaluronic Acid 
BC/PCL = Bacterial Cellulose/ PolyCaproLactone  
BCNC = Bacterial Cellulose NanoCrystals 
CGC = Critical Gelation Concentration 
CMC (1) = Carboxymethylcellulose 
CMC (2) = Critical Micelle Concentration 
DMARD = Disease-Modifying Anti-Rheumatic Drug 
DS = Degree of Substitution 
HA = Hyaluronic Acid 
HEMA = 2-HydroxyEthyl MethAcrylate 
K. xylinus = Komagataeibacter xylinus 
MTX = Methotrexate 
PCL = PolyCaproLactone  
PHEMA = Poly (2-HydroxyEthyl MethAcrylate) 
PVA = Poly Vinyl Alcohol  
RC = Regenerated Chitin 
RPE = Retinal Pigment Epithelium  
SEM = Scanning Electron Microscope 
SMN = Flavonoid Silymarin 
TEMPO = 2,2,6,6-Tetramethylpiperidine 1-oxyl radical 
TM = Tympanic Membrane  
TOBCP = TEMPO-Oxidized Bacterial Cellulose 
Pellicle 
UDPG = Uranyl Diphosphate-Glucose 
ε-PLL = ε-Poly-L-Lysine 
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